- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01689844
Randomized Trial of Tailored Dietary Advice to Lower Blood Pressure (FivePlus)
August 30, 2016 updated by: Edgar R. Miller, III, Johns Hopkins University
Five Plus Nuts and Beans Trial
The Five Plus Nuts & Beans Study is a randomized, controlled trial to compare two strategies for translating the results of the DASH (Dietary Approaches to Stop Hypertension) Study into practice for 120 African American participants who are on stable doses of antihypertensive medications.
The first arm of our study offers minimal DASH-oriented dietary advice along with a food credit at a local supermarket where they make their own decision of what to eat.
The second arm consists of a single one-hour session with a nutrition expert who provides choices and places an on-line order from a community grocery store (Santoni's Market) with targeted purchases of fruits, vegetables, nuts and beans.
Our primary outcome is change in blood pressure at 8 weeks.
Secondary outcomes are effects on glucose, uric acid, urine potassium excretion, and self-report consumption of fruits and vegetables during the same period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Unhealthy diets have many social determinants; however, there is a markedly lower availability of components of the DASH diet-recommended foods (such as fresh fruits and vegetables, skim milk and whole grain foods) in predominantly African-American and lower-income neighborhoods compared with Caucasian and higher-income neighborhoods.
Unhealthy dietary consumption patterns contribute, in part, to hypertension through deficiencies in potassium, magnesium and vitamin C - all micronutrients with independent blood pressure-lowering effects.
Furthermore, use of thiazide-based antihypertensive therapy often worsens deficiencies through increased urinary excretion.
Strategies that take into account the multi-level nature of the problem of poor nutrition among low income African Americans are needed to improve adherence to dietary recommendations and reverse micronutrient deficiencies in hypertensive adults.
The Five Plus Nuts & Beans Study is a randomized, controlled trial to compare two strategies for translating the results of the DASH (Dietary Approaches to Stop Hypertension) Study into practice for 120 African American participants who are on stable doses of antihypertensive medications.
The first arm of our study offers minimal DASH-oriented dietary advice along with a food credit at a local supermarket where they make their own decision of what to eat.
The second arm consists of a single one-hour session with a nutrition expert who provides choices and places an on-line order from a community grocery store (Santoni's Market) with targeted purchases of fruits, vegetables, nuts and beans.
Following the initial contact, there is a weekly call with the coordinator for a $30 per week food delivery.
Food orders are delivered for pick-up weekly by participants at a Baltimore Public Library in participant's neighborhood.
Our primary outcome is change in blood pressure at 8 weeks.
Secondary outcomes are effects on glucose, uric acid, urine potassium excretion, and self-report consumption of fruits and vegetables during the same period.
After completion of the active phase of the trial, we will follow blood pressures in the electronic medical record for one year to assess long-term effects.
Study Type
Interventional
Enrollment (Actual)
123
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21202
- Johns Hopkins Community Physicians, East Baltimore Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- must be age 21 or older,
- have a diagnosis of hypertension or pre-hypertension
- under regular care with their physician, and
- compliant with medications.
- systolic blood pressure of 120-140 mmHg and/or
- a diastolic blood pressure of 80-90 mmHg (average of two visits)
- on stable doses of antihypertensive medications for a minimum of two months prior to randomization, (and for the duration of the study).
- be able to follow all trial procedures.
Exclusion Criteria:
- cardiovascular event within 6 months,
- chronic disease that might interfere with trial participation (e.g. chronic kidney disease (estimated GFR < 60 cc/min),
- unwillingness or inability to adopt a DASH-like diet, and
- consumption of more than 14 alcoholic drinks per week,
- poorly controlled diabetes (Hemoglobin A1c >9%),
- use of insulin,
- use of mineral supplements or an unwillingness to stop supplements one month prior to randomization and refrain from the supplements during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Behavioral, DASH Plus - Dietary advice
This group will receive DASH diet advice and guided ordering of fruits, vegetables, nuts and beans that are high in potassium from a local supermarket.
|
DASH diet advice and guided shopping for high postassium foods at a local supermarket
|
|
Other: DASH - C
DASH C Group will receive brief DASH diet advice and will be able to make non- guided purchases of food products from the local supermarket.
|
Brief DASH dietary advice, No shopping guidance at the local supermarket.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: 8-wks follow-up
|
Daytime systolic blood pressure determined by OMRON 907-xl blood pressure monitoring, will be the primary outcome measurement
|
8-wks follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fasting glucose, lipids and uric acid; urine K and Na excretion
Time Frame: 8-wks follow-up
|
Fasting blood collections will occur in the morning after an overnight fast.
|
8-wks follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Edgar R Miller III, MD, PhD, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
April 27, 2012
First Submitted That Met QC Criteria
September 18, 2012
First Posted (Estimate)
September 21, 2012
Study Record Updates
Last Update Posted (Estimate)
August 31, 2016
Last Update Submitted That Met QC Criteria
August 30, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA00051935
- P50CA148087-01 (Other Grant/Funding Number: National Heart, Lung, and Blood Institute)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Blood Pressure
-
Indena S.p.ARecruitingHigh-normal Blood PressureItaly
-
GE HealthcareTerminatedBlood Pressure (Low, Normal, High)United States
-
Dow University of Health SciencesCompletedCognitive Change | Blood Pressure | Blood Glucose, HighPakistan
-
The Cleveland ClinicNot yet recruitingHypertension | Blood Pressure, High | Hypertension (HTN) | Blood Pressure ControlUnited States
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Centre Hospitalier Universitaire de la GuadeloupeRecruiting
-
Ouraring Inc.Recruiting
-
The University of NorthamptonCompletedHypertension | Blood Pressure, HighUnited Kingdom
Clinical Trials on DASH Plus
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHypertension | Type 2 Diabetes Mellitus (T2DM)United States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Hospital de Clinicas de Porto AlegreTerminated
-
Case Western Reserve UniversityCompleted
-
Texas Tech UniversityAlliance for Potato Research and EducationCompletedType 2 Diabetes | Blood PressureUnited States
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
Duke UniversityCompletedCardiovascular Diseases | Hypertension | Diet Modification | Women's Health | Digital HealthUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Rockefeller UniversityCompleted